What is Eversight?
Founded in 1947, Eversight has established itself as a leading nonprofit eye bank, dedicated to transforming lives by providing human eye tissue for transplantation and supporting critical research into blinding eye conditions. The organization's operations encompass tissue recovery, evaluation, and provision, alongside robust public and professional education initiatives to promote donation awareness. Eversight's commitment extends to humanitarian aid, supplying corneal tissue to those in need globally. The Eversight Center for Vision and Eye Banking Research in Cleveland serves as a hub for scientific inquiry, facilitating studies and advancing the fields of eye banking and ophthalmology.
How much funding has Eversight raised?
Eversight has raised a total of $25.2M across 3 funding rounds:
Series A
$9.7M
Private Equity
$14.5M
Private Equity
$1M
Series A (2014): $9.7M with participation from Emergence Capital Partners
Private Equity (2016): $14.5M led by Sutter Hill Ventures and Emergence Capital Partners
Private Equity (2016): $999K, investors not publicly disclosed
Key Investors in Eversight
Emergence Capital Partners
Emergence Capital Partners is a venture capital firm specializing in early-stage enterprise companies, aiming to be a valuable partner in transforming how the world works.
Sutter Hill Ventures
Sutter Hill Ventures is a venture capital firm with significant operating experience, focused on financing technology startups and assisting entrepreneurs in building market-leading companies.
What's next for Eversight?
The recent enterprise-level funding infusion positions Eversight for continued growth and expanded impact in its fight against corneal blindness. This strategic investment will likely fuel advancements in their global initiatives, which focus on building sustainable eye banking infrastructures in underserved communities, providing essential training for international eye surgeons and technicians, and supplying vital corneal tissue for transplantation and research. Eversight's ongoing collaboration with Vision Share and its dedication to research suggest a future focused on innovation and broader reach in restoring vision worldwide.
See full Eversight company page
